COMPETITION MATTERS
The Competition Tribunal has reached a R2-million settlement with pharmaceuticals group Adcock Ingram with regards to its proposed merger with BB Investment, a wholly owned subsidiary of the Bidvest Group. The Competition Commission earlier referred a complaint to the tribunal, alleging that Adcock Ingram and other respondents had possibly contravened section 13A(3) of the Competition Act, through the pre-implementation of the merger.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access